Sotirios StergiopoulosMD, BCMAS, FACP
Dr. Sotirios Stergiopoulos is Senior Vice President and Head of Global Medical Affairs and a member of the R&D Leadership team at Ipsen BioScience. Sotirios has a extensive experience in directing medical affairs worldwide strategies and plans and a solid expertise in Oncology drug development that includes chemotherapy, immunology drugs and targeted agents across various tumor indications. Sotirios’ past experience includes Vice President, Head of Global Medical Affairs Oncology at Baxalta (now Shire, Cambridge, MA), Executive Medical Director Oncology US Medical Affairs at Celgene Corporation (Summit, NJ), Senior Global Brand Medical Director Oncology at Novartis Pharmaceuticals (East Hanover, NJ) and Director Medical Affairs Oncology at Bayer Healthcare (Montville, NJ).
Dr. Stergiopoulos earned his M.D at the University of Medical Sciences of Poznan, Poland. He completed his residency in Internal Medicine at the Albert Einstein College of Medicine (NY), a clinical and research fellowship in Medical Genetics at Harvard Medical School and a research fellowship at National Institutes of Health where he had received an Intramural Research Training Award.
Dr. Stergiopoulos is currently an Attending Physician in the Department of Internal Medicine at Jacobi Medical Center, Albert Einstein College of Medicine (NY). In addition, he holds a Masters in Biotechnology Enterprise and Entrepreneurship (MBEE) from The Johns Hopkins University (Baltimore, MD). Sotirios is a Fellow of the New York Academy of Medicine as well as the Royal Society of Medicine (UK). He also is a Member of the American Association of Cancer Research, American Society of Clinical Oncology, and sits on multiple Boards as well as Chairman of Board of A2A Pharmaceuticals, a fragment based computational drug design company.